Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 3
2003 7
2004 7
2005 6
2006 7
2007 6
2008 7
2009 8
2010 9
2011 7
2012 6
2013 5
2014 5
2015 8
2016 9
2017 2
2018 1
2020 5
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. Among authors: verheijen rh. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Free article. Clinical Trial.
Notch signaling in serous ovarian cancer.
Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR. Groeneweg JW, et al. Among authors: verheijen rh. J Ovarian Res. 2014 Nov 4;7:95. doi: 10.1186/s13048-014-0095-1. J Ovarian Res. 2014. PMID: 25366565 Free PMC article. Review.
Ovarian carcinogenesis: an alternative hypothesis.
Piek JM, van Diest PJ, Verheijen RH. Piek JM, et al. Among authors: verheijen rh. Adv Exp Med Biol. 2008;622:79-87. doi: 10.1007/978-0-387-68969-2_7. Adv Exp Med Biol. 2008. PMID: 18546620 Review.
HPV testing in cervical screening.
Brink AA, Snijders PJ, Meijer CJ, Berkhof J, Verheijen RH. Brink AA, et al. Among authors: verheijen rh. Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):253-66. doi: 10.1016/j.bpobgyn.2005.10.009. Epub 2005 Dec 13. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16359926 Review.
The role of hypoxia inducible factor-1alpha in gynecological cancer.
Seeber LM, Horrée N, Vooijs MA, Heintz AP, van der Wall E, Verheijen RH, van Diest PJ. Seeber LM, et al. Among authors: verheijen rh. Crit Rev Oncol Hematol. 2011 Jun;78(3):173-84. doi: 10.1016/j.critrevonc.2010.05.003. Epub 2010 Jun 7. Crit Rev Oncol Hematol. 2011. PMID: 20627616 Review.
Patient engagement in research on rare gynecological tumors.
Roze J, Groeneweg J, Monroe G, Fransen I, Gultekin M, Zweemer R, Verheijen RHM. Roze J, et al. Among authors: verheijen rhm. Int J Gynecol Cancer. 2020 Dec;30(12):2012-2014. doi: 10.1136/ijgc-2020-001555. Epub 2020 Jun 2. Int J Gynecol Cancer. 2020. PMID: 32487683 No abstract available.
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer.
van der Zee AG, Colombo N, Gitsch G, Reed N, Amant F, Cibula D, Kesic VI, Kimmig R, Lopes AD, Markowska J, Marth C, Radolakis A, Salvesen H, Vaitkiene D, Verheijen RH, Zola P. van der Zee AG, et al. Among authors: verheijen rh. Int J Gynecol Cancer. 2012 Jan;22(1):175. doi: 10.1097/IGC.0b013e3182261f15. Int J Gynecol Cancer. 2012. PMID: 22193647 No abstract available.
100 results